Payments to Acquire Property, Plant, and Equipment of ROCKET PHARMACEUTICALS, INC. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ROCKET PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • ROCKET PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $364,000, a 82% decline year-over-year.
  • ROCKET PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $440,000, a 92% decline from 2024.
  • ROCKET PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $5,862,000, a 64% decline from 2023.
  • ROCKET PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $16,436,000, a 97% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

ROCKET PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $440,000 -$5,422,000 -92% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $5,862,000 -$10,574,000 -64% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $16,436,000 +$8,078,000 +97% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $8,358,000 +$738,000 +9.7% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $7,620,000 -$12,987,000 -63% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $20,607,000 -$2,662,000 -11% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $23,269,000 +$21,816,000 +1501% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,453,000 +$693,000 +91% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $760,000 +$425,000 +127% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $335,000 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019 2018 FY

ROCKET PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $364,000 -$1,671,000 -82% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $2,035,000 -$980,000 -33% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $3,015,000 +$1,060,000 +54% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $1,955,000 +$1,627,000 +496% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $328,000 -$4,879,000 -94% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $5,207,000 +$4,447,000 +585% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $760,000 +$752,000 +9400% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $8,000 -$123,000 -94% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $131,000 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.